<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7138017\results\search\testTrace\results.xml">
  <result pre="COVID-19 resource centre remains active. The 2019 novel coronavirus (2019-nCoV)" exact="infection" post="can lead to acute resolved or fatal pneumonia. On"/>
  <result pre="(66Â·16% of total cases) and 414 deaths from 2019 nCoV" exact="infection" post="(97Â·41% of total deaths in China). 632 patients with"/>
  <result pre="(97Â·41% of total deaths in China). 632 patients with confirmed" exact="infection" post="have recovered and have been discharged from hospital. However,"/>
  <result pre="hospital. However, the downward turning point for new cases of" exact="infection" post="has not been observed yet (figure ). Notably, 159"/>
  <result pre="of this virus.1 Their achievement not only improves methods of" exact="diagnosis" post="confirmation in clinics but also promotes the study of"/>
  <result pre="nucleic acid assay using RT-PCR was quickly developed for the" exact="diagnosis" post="of 2019-nCoV infection.3, 4 Additionally, human angiotensin-converting enzyme 2"/>
  <result pre="zoonotic virus, but whether an intermediate host facilitated the viral" exact="infection" post="in humans is still unknown.7 Lastly, evidence of person-to-person"/>
  <result pre="the next crucial step would be to identify the proper" exact="treatment" post="for patients infected with 2019-nCoV. No fully proven and"/>
  <result pre="patients infected with 2019-nCoV. No fully proven and specific antiviral" exact="treatment" post="for the coronavirus exists. Guidance from China's National Health"/>
  <result pre="use of remdesivir, in the first diagnosed patient with 2019-nCoV" exact="infection" post="in the USA,14 has encouraged additional clinical study of"/>
  <result pre="reports of lung pathology in patients who died from 2019-nCoV" exact="infection" post="have been reported so far. Notably, elderly men with"/>
  <result pre="have been reported so far. Notably, elderly men with 2019-nCoV" exact="infection" post="and other underlying diseases often have a higher fatality"/>
  <result pre="The development of more efficient and quicker methods for the" exact="detection" post="of viral nucleic acids is needed to ensure the"/>
  <result pre="treatment, and prevention of 2019-nCoV-associated disease.19 Novel therapeutic approaches, including" exact="treatment" post="with allogeneic mesenchymal stem cells, are expected to progress"/>
  <result pre="expected to progress to clinical trials involving patients with 2019-nCoV" exact="infection" post="in a critical condition when the projects meet both"/>
  <result pre="the occurrence of new infections, which will help the in-time" exact="diagnosis" post="and treatment of patients and protect the healthy population"/>
  <result pre="of new infections, which will help the in-time diagnosis and" exact="treatment" post="of patients and protect the healthy population against viral"/>
  <result pre="treatment of patients and protect the healthy population against viral" exact="infection" post="not only in China but also in the rest"/>
  <result pre="remain the early detection, early diagnosis, early isolation, and early" exact="treatment" post="of the disease. With the huge efforts from medical"/>
  <result pre="2019 novel coronavirus (2019-nCoV) by real-time RT-PCREuro Surveill2520202000045 4collab: WHOLaboratory" exact="testing" post="of human suspected cases of novel coronavirus (nCoV) infection:"/>
  <result pre="descriptive studyLancet2020published online Jan 2910.1016/S0140-6736(20)30211-7 13ChuCMRole of lopinavir/ritonavir in the" exact="treatment" post="of SARS: initial virological and clinical findingsThorax59200425225614985565 14HolshueMLDeBoltCLindquistSFirst case"/>
  <result pre="recent insights into emerging coronavirusesNat Rev Microbiol14201652353427344959 16RotheCSchunkMSothmannPTransmission of 2019-nCoV" exact="infection" post="from an asymptomatic contact in GermanyN Engl J Med2020published"/>
 </snippets>
</snippetsTree>
